A Clinical Trial to Assess the Safety, Tolerability, and Immunogenicity of MenABCWY in Healthy Infants
A Clinical Trial to Assess the Safety, Tolerability, and Immunogenicity of MenABCWY in Healthy Infants. A Phase 2b Trial to Assess the Safety, Tolerability, and Immunogenicity of MenABCWY in Healthy Infants 2 and 6 Months of Age.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06886992
ClinicalTrials.gov Identifier (NCT): NCT04645966
Protocol ID: C3511002
Open Plain Language Summary Result:
Click here